C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer.
BJU Int. 2005 May;95(7):961-2. doi: 10.1111/j.1464-410X.2005.05447.x.
BJU Int. 2005.
PMID: 15839913